6.44
Schlusskurs vom Vortag:
$6.11
Offen:
$6.47
24-Stunden-Volumen:
109.36K
Relative Volume:
0.80
Marktkapitalisierung:
$4.32M
Einnahmen:
$49,300
Nettoeinkommen (Verlust:
$-6.27M
KGV:
-0.7085
EPS:
-9.09
Netto-Cashflow:
$-5.38M
1W Leistung:
+4.89%
1M Leistung:
-6.60%
6M Leistung:
-13.09%
1J Leistung:
+109.23%
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Vergleichen Sie ACON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ACON
Aclarion Inc
|
6.44 | 4.10M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
223.26 | 37.72B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.61 | 13.14B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.79 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.85 | 8.31B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
36.54 | 6.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Growth Value: Can GCT Semiconductor Holding Inc stock weather global recessionJuly 2025 Trends & AI Powered Market Entry Ideas - moha.gov.vn
What drives Aclarion Inc stock priceReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Aclarion shares move higher after Nociscan highlighted in spine surgery journal - MSN
Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - Orthopedics This Week
Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Aclarion Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria
Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser
Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser
How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser
Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative
Aclarion stock rises after feature in special pain issue of spine journal By Investing.com - Investing.com South Africa
Aclarion stock rises after feature in special pain issue of spine journal - Investing.com Canada
Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com
Aclarion announces publication of Nociscan article in pain issue of IJSS - TipRanks
Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative
Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan
Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser
Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser
Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser
Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com
Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph
Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks
Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - 富途牛牛
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - The Globe and Mail
Is Aclarion's Debt-Free Position The Backbone Of Its Next Phase Of Expansion? - RTTNews
2 innovative micro-cap stocks for 2026 - MSN
2 innovative micro-cap stocks for 2026 | 2025-12-01 | Investing News - Stockhouse
Is Aclarion Inc Equity Warrant a good long term investmentEarnings Forecast Updates & Affordable Growth Investments - earlytimes.in
Momentum Shift: Why Aclarion Inc. stock appeals to dividend seekersQuarterly Risk Review & Precise Buy Zone Identification - moha.gov.vn
Can Aclarion Inc. stock hit record highs againInflation Watch & Fast Moving Market Watchlists - moha.gov.vn
What margin trends mean for Aclarion Inc. stockMarket Activity Summary & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ
Aclarion loss widens, but balance sheet remains strong - BizWest
Is Aclarion Inc a good long term investmentLarge Cap Stability Picks & Access Our Free Weekly Investment Letter - earlytimes.in
Critical Review: Aclarion (ACON) vs. The Competition - Defense World
Aclarion Inc. (ACON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Aclarion Inc. (IT20) stock stays on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com
Is Aclarion Inc. Equity Warrant stock trading near support levels2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Positive Outlook on Aclarion, Inc. Driven by Revenue Growth and Strategic Investments - TipRanks
Ascendiant Capital Maintains Aclarion (ACON) Buy Recommendation - Nasdaq
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Aclarion (ACON) Sees Price Target Boost by Ascendiant Capital | - GuruFocus
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):